Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Distinct type 2-high inflammation associated molecular signatures of chronic rhinosinusitis with nasal polyps with comorbid asthma
Ming Wang, Xiangting Bu, Ge Luan, et al.
Clinical and Translational Allergy (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 48

Showing 1-25 of 48 citing articles:

Efficacy and safety of benralizumab in chronic rhinosinusitis with nasal polyps: A randomized, placebo-controlled trial
Claus Bachert, Joseph K. Han, Martin Y. Desrosiers, et al.
Journal of Allergy and Clinical Immunology (2021) Vol. 149, Iss. 4, pp. 1309-1317.e12
Open Access | Times Cited: 221
Endotypes of chronic rhinosinusitis: Relationships to disease phenotypes, pathogenesis, clinical findings, and treatment approaches
Atsushi Kato, Anju T. Peters, Whitney W. Stevens, et al.
Allergy (2021) Vol. 77, Iss. 3, pp. 812-826
Open Access | Times Cited: 166
Cost burden and resource utilization in patients with chronic rhinosinusitis and nasal polyps
Neil Bhattacharyya, Sara Villeneuve, Vijay N. Joish, et al.
The Laryngoscope (2019) Vol. 129, Iss. 9, pp. 1969-1975
Open Access | Times Cited: 158
Dupilumab improves upper and lower airway disease control in chronic rhinosinusitis with nasal polyps and asthma
Tanya M. Laidlaw, Claus Bachert, Nikhil Amin, et al.
Annals of Allergy Asthma & Immunology (2021) Vol. 126, Iss. 5, pp. 584-592.e1
Open Access | Times Cited: 85
Tezepelumab Efficacy in Patients with Severe, Uncontrolled Asthma with Comorbid Nasal Polyps in NAVIGATOR
Tanya M. Laidlaw, Andrew Menzies‐Gow, Scott Caveney, et al.
Journal of Asthma and Allergy (2023) Vol. Volume 16, pp. 915-932
Open Access | Times Cited: 27
Real‐World Adverse Events After Type 2 Biologic use in Chronic Rhinosinusitis with Nasal Polyps
Marisa Dorling, Juan Carlos Hernaiz‐Leonardo, Athenea Pascual, et al.
The Laryngoscope (2024) Vol. 134, Iss. 7, pp. 3054-3059
Open Access | Times Cited: 14
Dupilumab (Dupixent®) tends to be an effective therapy for uncontrolled severe chronic rhinosinusitis with nasal polyps: real data of a single-centered, retrospective single-arm longitudinal study from a university hospital in Germany
Florian Jansen, Benjamin Becker, Jördis Kristin Eden, et al.
European Archives of Oto-Rhino-Laryngology (2022) Vol. 280, Iss. 4, pp. 1741-1755
Open Access | Times Cited: 31
The Unified Airway Hypothesis: Evidence From Specific Intervention With Anti–IL-5 Biologic Therapy
Claus Bachert, Amber Luong, Philippe Gevaert, et al.
The Journal of Allergy and Clinical Immunology In Practice (2023) Vol. 11, Iss. 9, pp. 2630-2641
Open Access | Times Cited: 21
Sense of smell in chronic rhinosinusitis: A multicentric study on 811 patients
Alberto Macchi, Alessia Giorli, Elena Cantone, et al.
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 20
Thymic Stromal Lymphopoietin and Tezepelumab in Airway Diseases: From Physiological Role to Target Therapy
Diego Bagnasco, Laura De Ferrari, Benedetta Bondi, et al.
International Journal of Molecular Sciences (2024) Vol. 25, Iss. 11, pp. 5972-5972
Open Access | Times Cited: 6
The Role of Biologics in Chronic Rhinosinusitis With Nasal Polyps
Gayatri Patel, Anju T. Peters
Ear Nose & Throat Journal (2020) Vol. 100, Iss. 1, pp. 44-47
Open Access | Times Cited: 45
Mechanism of protective effect of xuan-bai-cheng-qi decoction on LPS-induced acute lung injury based on an integrated network pharmacology and RNA-sequencing approach
Huahe Zhu, Shun Wang, Shan Cong, et al.
Respiratory Research (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 40
Biologics for severe uncontrolled chronic rhinosinusitis with nasal polyps: a change management approach. Consensus of the Joint Committee of Italian Society of Otorhinolaryngology on biologics in rhinology
Eugenio De Corso, Gianluca Bellocchi, Michele De Benedetto, et al.
Acta Otorhinolaryngologica Italica (2021) Vol. 42, Iss. 1, pp. 1-16
Open Access | Times Cited: 33
Prevalence of type 2 inflammatory signatures and efficacy of dupilumab in patients with chronic rhinosinusitis with nasal polyps from two phase 3 clinical trials: SINUS‐24 and SINUS‐52
Claus Bachert, Asif Khan, Stella E. Lee, et al.
International Forum of Allergy & Rhinology (2023) Vol. 14, Iss. 3, pp. 668-678
Open Access | Times Cited: 14
Biologics in severe uncontrolled chronic rhinosinusitis with nasal polyps: A bicentric experience.
Gianluca Bellocchi, Antonella Loperfido, Francesco Maria Passàli, et al.
PubMed (2023) Vol. 94, Iss. 5, pp. e2023227-e2023227
Closed Access | Times Cited: 11
Proteomic and metabolomic proof of concept for unified airways in chronic rhinosinusitis and asthma
Yao Yao, Yujuan Yang, Jianwei Wang, et al.
Annals of Allergy Asthma & Immunology (2024) Vol. 132, Iss. 6, pp. 713-722.e4
Closed Access | Times Cited: 4
SerpinB3/B4 Abates Epithelial Cell-Derived CXCL8/IL-8 Expression in Chronic Rhinosinusitis with Nasal Polyps
Xiangting Bu, Ming Wang, Jing Yuan, et al.
Journal of Immunology Research (2024) Vol. 2024, pp. 1-13
Open Access | Times Cited: 4
Nasal brushing molecular endotyping distinguishes patients with chronic rhinosinusitis with nasal polyps with better response to dupilumab
Kaitlyn Gayvert, Martin Desrosiers, Tanya M. Laidlaw, et al.
Journal of Allergy and Clinical Immunology (2024) Vol. 154, Iss. 3, pp. 619-630
Open Access | Times Cited: 4
Real‐world predictors of dupilumab prescription in patients with chronic rhinosinusitis with nasal polyps
Christina Dorismond, Mason R. Krysinski, Yash Trivedi, et al.
International Forum of Allergy & Rhinology (2024)
Open Access | Times Cited: 4
Predictive significance of 15(S)-hydroxyeicosatetraenoic acid for eosinophilic chronic rhinosinusitis with nasal polyps
Ying Li, Bing Yan, Bangyu Cui, et al.
Asia Pacific Allergy (2025)
Open Access
The immunology of asthma and chronic rhinosinusitis
Atsushi Kato, Hirohito Kita
Nature reviews. Immunology (2025)
Closed Access
Expression of Oxidative Stress and Inflammation-Related Genes in Nasal Mucosa and Nasal Polyps from Patients with Chronic Rhinosinusitis
Hrvoje ̧Mihalj, Josip Butković, Stana Tokić, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 10, pp. 5521-5521
Open Access | Times Cited: 16
Insights into the epigenetics of chronic rhinosinusitis with and without nasal polyps: a systematic review
Tripti Brar, Lisa Marks, Devyani Lal
Frontiers in Allergy (2023) Vol. 4
Open Access | Times Cited: 8
Systematic Review of Protein Biomarkers in Adult Patients With Chronic Rhinosinusitis
Shyam Gokani, Andreas Espehana, Ana C. Pratas, et al.
American Journal of Rhinology and Allergy (2023) Vol. 37, Iss. 6, pp. 705-729
Open Access | Times Cited: 8
Cost-effectiveness analysis of biologics for the treatment of chronic rhinosinusitis with nasal polyps in Canada
Michael Yong, Keshinisuthan Kirubalingam, Martin Y. Desrosiers, et al.
Allergy Asthma and Clinical Immunology (2023) Vol. 19, Iss. 1
Open Access | Times Cited: 8
Page 1 - Next Page

Scroll to top